The Post Traumatic Stress Disorder (PTSD) Market To Surge with a CAGR of 8.3% in the 7MM During the Study Period (2019-32) | DelveInsight

LAS VEGAS, May 10, 2022 /PRNewswire/ -- The dynamics of the Post Traumatic Stress Disorder market is anticipated to change as the key players, such as Jazz Pharmaceuticals, Aptinyx, Otsuka Pharmaceutical and Bionomics Limited are involved in the development of Post Traumatic Stress Disorder treatment. The projected introduction of these methods might get an advantage in Post Traumatic Stress Disorder market space due in the course. 

DelveInsight's Post Traumatic Stress Disorder (PTSD) Market Insights report includes a comprehensive understanding of current treatment practices, Post Traumatic Stress Disorder emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM (the United States, the EU5 (the United Kingdom, Italy, Spain, France, and Germany), and Japan.

Key Takeaways from the Post Traumatic Stress Disorder Market

• As per DelveInsight analysis, the Post Traumatic Stress Disorder market size was over USD 1,740.2 billion in 2021, which is further expected to increase by 2032.
• As per the estimates, the total Post Traumatic Stress Disorder diagnosed 12-month prevalent cases in the 7MM was more than 5 million in 2021. 
• Key Post Traumatic Stress Disorder companies such as Jazz Pharmaceuticals, Aptinyx, Otsuka Pharmaceutical Development & Commercialization, Inc., Bionomics Limited, Nobilis Therapeutics,H. Lundbeck A/S, Boehringer Ingelheim, AstraZeneca, Remedy, Pfizer, Tonix Pharmaceuticals, Inc., and others are currently working to develop drugs for Resistant Hypertension that will launch in the Post Traumatic Stress Disorder market in the upcoming years.
• The Post Traumatic Stress Disorder therapies in the pipeline include JZP150, NYX-783, Rexulti (brexpiprazole) and Zoloft (sertraline) combination, BNC210, and others.
• The Post Traumatic Stress Disorder testing market is expected to grow significantly owing to an increase in prevalence due to increase in life stressors, traumatic event,less competitive scenario, and increased initiatives to create public awareness and knowledge of the disease., The growth in the market 

Discover more about therapies set to grab major Post Traumatic Stress Disorder market share @ Post Traumatic Stress Disorder Market Landscape

Post Traumatic Stress Disorder

Post Traumatic Stress Disorder (PTSD) has been defined as "the complex physical, cognitive, emotional, and behavioral consequences of psychological trauma." It is characterized by intrusive thoughts, nightmares, flashbacks to past traumatic events, avoidance of traumatic reminders, hypervigilance, and sleep disturbance, all of which contribute to significant social, occupational, and interpersonal dysfunction. Post Traumatic Stress Disorder causes include feelings like intense fear, helplessness, and horror. 

Post Traumatic Stress Disorder symptoms can occur as soon as a month after a stressful experience, but they can also appear years later. These symptoms generate substantial issues in social and work circumstances, as well as in relationships. They can also impair one's capacity to carry out routine everyday chores. Post Traumatic Stress Disorder symptoms are classified into four types: intrusive recollections, avoidance, unfavorable changes in thinking and mood, and changes in physical and emotional reactions. Symptoms may change over time or from person to person. 

For the Post Traumatic Stress Disorder diagnosis, the doctor will most likely perform a physical exam to rule out any medical issues that may be causing the symptoms – a psychological evaluation that includes a discussion of the signs and symptoms, as well as the event or events that precipitated them, and will employ the criteria from the Diagnostic and Statistical Manual of Mental Disorders (DSM-5).

Post Traumatic Stress Disorder Epidemiology Segmentation

As per DelveInsight, the total Post Traumatic Stress Disorder diagnosed 12-month prevalent cases in the 7MM was more than 5 million in 2021.

Among the 7MM, the United States has the highest prevalent cases of Post Traumatic Stress Disorder in 2021.

The Post Traumatic Stress Disorder Market Report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:

• Prevalence population of  PTSD 
• Diagnosed prevalent Cases of PTSD 
• Gender-specific Cases of PTSD 
• Severity-specific Cases of PTSD 
• Age-specific Cases of PTSD 
• Total Treated cases of PTSD 

Download the report to understand which factors are driving Post Traumatic Stress Disorder epidemiology trends @ Post Traumatic Stress Disorder Epidemiological Insights

Post Traumatic Stress Disorder Treatment Market

A multidimensional strategy is used in the Post Traumatic Stress Disorder treatment for patients. Patient education, social support, and anxiety control through psychotherapy and psychopharmacological intervention are all treatment possibilities. Patient education and social support are critical early measures for engaging the patient and mitigating the impact of the traumatic experience. Local and national support groups can assist to de-stigmatize mental health diagnoses and emphasize that Post Traumatic Stress Disorder symptoms are more than just a reaction to stress and require treatment. Family and friend support fosters understanding and acceptance, which may lessen survivor guilt. Psychotherapy and counseling, medicine, or a mix of the two are commonly used in Post Traumatic Stress Disorder treatment.

There are numerous methods of psychotherapy, commonly known as talk therapy, that can be used to treat children and adults with PTSD. Cognitive therapy, exposure therapy, and eye movement desensitization (EMDR) and reprocessing are all types of psychotherapy utilized in the Post Traumatic Stress Disorder treatment.

Furthermore, with a few promising therapies for Post Traumatic Stress Disorder in the pipeline, the Post Traumatic Stress Disorder market size is projected to grow. Among the emerging therapies, the most promising ones include JZP150 (Jazz Pharmaceuticals), NYX-783 (Aptinyx), BNC210 (Bionomics Limited), and others.

Discover more about therapy set to grab substantial Post Traumatic Stress Disorder market share @ Best Therapy for Post Traumatic Stress Disorder Treatment 

Post Traumatic Stress Disorder Pipeline Therapies and Key Players

• JZP150: Jazz Pharmaceuticals
• NYX-783: Aptinyx
• BNC210: Bionomics Limited
• Rexulti (brexpiprazole) and Zoloft (sertraline) combination: Otsuka Pharmaceutical/ Lundbeck

To know about more new drugs for Post Traumatic Stress Disorder treatment visit @ Drugs to treat Post Traumatic Stress Disorder

Post Traumatic Stress Disorder Market Dynamics

The introduction of novel drugs and classes of new therapeutic drugs for treatment into the Post Traumatic Stress Disorder market will give PTSD patients hope as a treatment option and may have a significant positive impact on the Post Traumatic Stress Disorder market. Moreover, new diagnostic categories based on PTSD such as Prolonged duress stress disorder, post-traumatic mourning disorder, post-traumatic relationship syndrome, post-traumatic dental care anxiety, and post-traumatic abortion syndrome have all been proposed which will further boost the Post Traumatic Stress Disorder market. Furthermore, the increase in the prevalence and rise in initiatives to create public awareness and knowledge of the disease are also contributing to the growth of the Post Traumatic Stress Disorder market. In addition, a less competitive scenario will create an opportunity for the new players to enter into the Post Traumatic Stress Disorder market. 

However, certain factors are limiting the growth of the Post Traumatic Stress Disorder market. The main drawback of PTSD is that it is associated with high rates of comorbidities, psychiatric and medical diseases, as well as alcohol and drug abuse, resulting in poor QOL and poor physical health, thus impeding the growth of the Post Traumatic Stress Disorder market. In addition, the heterogeneity of the symptoms and delayed onset of PTSD are acting as a barrier to the growth of the Post Traumatic Stress Disorder market. Moreover, with the expiration of patent protection for many pharmaceuticals and rising health-care costs, the entry of generics occurs, posing a significant challenge to the Post Traumatic Stress Disorder market. 

Scope of the Post Traumatic Stress Disorder Market Report

• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Post Traumatic Stress Disorder Companies: Jazz Pharmaceuticals, Aptinyx, Otsuka Pharmaceutical Development & Commercialization, Inc., Bionomics Limited, Nobilis Therapeutics,H. Lundbeck A/S, Boehringer Ingelheim, AstraZeneca, Remedy, Pfizer, Tonix Pharmaceuticals, Inc., and others
• Key Post Traumatic Stress Disorder Pipeline Therapies: JZP150, NYX-783, Rexulti (brexpiprazole) and Zoloft (sertraline) combination, BNC210, and others
• Post Traumatic Stress Disorder Therapeutic Assessment: Post Traumatic Stress Disorder current marketed and emerging therapies
• Post Traumatic Stress Disorder Market Dynamics:  Post Traumatic Stress Disorder market drivers and barriers 
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Unmet Needs, KOL's views, Analyst's views, Post Traumatic Stress Disorder Market Access and Reimbursement

Discover more about the future Post Traumatic Stress Disorder market share of treatment therapies @ Post Traumatic Stress Disorder Treatment Drugs

Table of Contents

Get in touch with our Business executive  @ Healthcare Due Diligence Services 

Related Reports

Post Traumatic Stress Disorder Epidemiology

Post Traumatic Stress Disorder Epidemiology Forecast to 2032 report delivers an in-depth understanding of the disease, historical, and forecasted Post Traumatic Stress Disorder epidemiology in the 7MM.

Post Traumatic Stress Disorder Pipeline

Post Traumatic Stress Disorder Pipeline Insight, 2022 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key Post Traumatic Stress Disorder companies involved such as Aptinyx, Jazz Pharmaceuticals, Bionomics Limited, among others.

Bipolar Depression Market

Bipolar Depression Market Insights, Epidemiology, and Market Forecast-2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key Bipolar Depression companies such as  Intra-Cellular Therapies, Sunovion Pharmaceuticals, COMPASS Pathways, among others.

Schizophrenia Market

Schizophrenia Market Insights, Epidemiology, and Market Forecast-2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key Schizophrenia companies such as  Neurocrine Bioscience, Takeda Pharmaceutical Company, Memory Pharmaceuticals, among others.

Epilepsy Market

Epilepsy Market Insights, Epidemiology, and Market Forecast-2030 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key Epilepsy companies such as Eisai Co.LTD., Alexza Pharmaceuticals, Xenon Pharmaceuticals, among others.

Migraine Market

Migraine Market Insights, Epidemiology, and Market Forecast-2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key Migraine companies such as Satsuma Pharmaceuticals, Biohaven Pharmaceuticals, Allodynic Therapeutics, among others.

Other Trending Reports

Hairy Cell Leukemia (HCL) Market

"Hairy Cell Leukemia (HCL) Market" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Hairy Cell Leukemia (HCL) market size, share, and trends in the 7MM. Some of the key companies in the Hairy Cell Leukemia (HCL) Therapeutics Market include AstraZeneca, Janssen, Merck, Pharmacyclics, Johnson and Johnson, Roche, Innate Pharma, and others. 

Hypereosinophilic Syndrome Market

"Hypereosinophilic Syndrome Market" research report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Hypereosinophilic Syndrome market size, share, and trends in 7MM. Some of the key companies in the Hypereosinophilic Syndrome Market include AstraZeneca, GlaxoSmithKline, Knopp Biosciences, and others.

Glomerulonephritis Market

"Glomerulonephritis Market" research report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Glomerulonephritis market size, share, and trends in the 7MM. Some of the key companies in the Glomerulonephritis Therapeutics Market include Alexion Pharmaceuticals, Novartis Pharmaceuticals, Alnylam Pharmaceuticals, Apellis Pharmaceuticals, Otsuka, Omeros Corporation, and others. 

Charcot-Marie-Tooth Disease Market

"Charcot-Marie-Tooth Disease Market" research report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Charcot-Marie-Tooth Disease market size, share, and trends in the 7MM. The key player in the Charcot-Marie-Tooth Disease Therapeutics Market includes Pharnext. 

Mucinous Cystic Neoplasms (MCNs) Market

"Mucinous cystic neoplasms (MCNs) Market" research report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Mucinous Cystic Neoplasms market size, share, and trends in the 7MM. The major player in the Mucinous Cystic Neoplasms (MCNs) Therapeutics Market include NanOlogy LLC. 

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.  Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Connect With Us at LinkedIn | Facebook | Twitter

Contact Us
Shruti Thakur 
info@delveinsight.com 
+1(919)321-6187 
www.delveinsight.com

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg